Scientist, Sterile Products Development
Posted on: 5 Feb 2021
New Brunswick, NJ
Job Description
At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
The division of Global Product Supply at Bristol-Myers Squibb is seeking a highly motivated scientist to join our Sterile Products Development group. The successful applicant will be primarily responsible for the technical and strategic advancement of biologic drug candidates in support of formulation and process optimization throughout all stages of clinical and commercial drug product development.
This individual should have demonstrated detailed fundamental knowledge of protein separation and characterization including chemical stability, physical stability and interactions with common excipients. Hands-on experience with analytical and biophysical characterization techniques for monitoring and investigating protein property and stability under physiologically or pharmaceutically relevant conditions is also required. Additional knowledge of chemical biology concepts, gene therapy and viral vector characterization is also highly desirable.
The successful candidate must have a passion for problem solving and a keen sense of innovation, along with excellent interpersonal communication skills and enthusiasm for working with multidisciplinary teams for developing and advancing biologic drug products. This requires rigorous design and execution of experiments, promoting novel applications and advancements of technologies, in addition to high standards of laboratory safety, documentation, and interpretation and presentation of scientific results, both independently and collaboratively.
Qualifications:
The successful candidate must have an advanced degree in chemistry, biochemistry, engineering or related field, with 0-3 years of relevant industrial or postdoctoral experience required with a PhD degree, or a minimum of 5 years of experience with a M.S. degree.
The successful candidate must have demonstrated knowledge and hands-on experience with various protein separation (chromatographic and electrophoretic) techniques. Experience or working knowledge of gene therapy and viral vector analysis, characterization of lipid nano particles, and mass spectroscopy technique is a plus.
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Bristol-Myers Squibb
New York, New York
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company’s products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.
It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. It has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; and FameWave Ltd.
The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.
-
IndustryBiopharmaceuticals
-
No. of Employees23, 300
-
Website
-
Jobs Posted1641
